BridgeBio Pharma, Inc. announced that it will present research findings related to its drug acoramidis for treating variant transthyretin amyloid cardiomyopathy (ATTR-CM) at the upcoming Annual ...

Annovis Bio will present data on Alzheimer’s and Parkinson’s therapies at the AD/PD™ 2025 conference in Vienna. Annovis Bio Inc. announced its participation in the AD/PD™ 2025 conference, scheduled ...

-- Gene therapy program VTX-806 demonstrated normalization of toxic bile acid metabolites in blood, liver, tendons and brain in a CTX mouse model for the first time, holding promise for curative ...

Dementia experts from UC San Francisco will present research at the annual Clinical Trials on Alzheimer’s Disease (CTAD) conference in San Francisco. The CTAD conference will feature top neurologists, ...

Presentations highlight the utility of using real-world data to drive precision medicine forward TAMPA, Fla., April 7, 2023 /PRNewswire/ -- M2GEN, an oncology-focused health informatics solutions ...

Researchers from Mass General Brigham and the Mass General Brigham Gene and Cell Therapy Institute – a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials ...

The Family Heart Foundation, the leading research, education and advocacy organization focused on genetic dyslipidemias, today announced it will share key research findings and data at the 2025 ...